Stoke Therapeutics Inc. (STOK)

7.38

-0.47 (-5.99%)

At close: Mar 03, 2025, 3:59 PM

7.40

0.20%

After-hours: Mar 03, 2025, 04:00 PM EST

Stoke Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Net Income	-104.7M	-101.07M	-85.81M	-52.24M	-32.33M	-12.52M	-5.56M
Depreciation & Amortization	2.47M	1.55M	974K	888K	450K	214K	113K
Stock-Based Compensation	25.26M	22.85M	16.45M	5.77M	1.92M	240K	26K
Other Working Capital	-2.82M	42.9M	-2.85M	-2.88M	-2M	1.09M	31K
Other Non-Cash Items	1.94M	1.78M	1.26M	1.04M	3K	10K	4K
Deferred Income Tax	n/a	n/a	172K	3K	n/a	n/a	n/a
Change in Working Capital	-6.03M	43.02M	46K	2.33M	-1.1M	1.09M	31K
Operating Cash Flow	-81.07M	-31.87M	-66.91M	-42.22M	-31.05M	-10.96M	-5.38M
Capital Expenditures	-1.62M	-3.96M	-1.2M	-1.05M	-1.64M	-935K	-113K
Acquisitions	n/a	45.34M	75.23M	n/a	1K	10K	n/a
Purchase of Investments	n/a	-201.32M	-87.23M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	107.56M	159.4M	12M	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-45.34M	-75.23M	n/a	1K	10K	n/a
Investing Cash Flow	105.95M	-45.88M	-76.43M	-1.05M	-1.63M	-925K	-113K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	926K	1.06M	1.28M	2.71M	-2.15M	115.64M	5.97M
Financial Cash Flow	53.01M	46.41M	1.28M	108.11M	149.76M	115.64M	5.97M
Net Cash Flow	77.89M	-31.34M	-142.05M	64.84M	117.07M	103.75M	477K
Free Cash Flow	-82.68M	-35.83M	-68.11M	-43.27M	-32.69M	-11.9M	-5.5M